methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate

C61H76F4N10O8 — CID 88588746

IUPACmethyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1[C@H](c2nc3cc(F)c([C@H]4CC[C@H](c5cc6[nH]c([C@@H]7C[C@@H]8CCC[C@@H]8N7C(=O)[C@@H](NC(=O)OC)C7CCOCC7)nc6cc5F)N4C4=CC(F)=C(N5CCCCC5)C(F)C4)cc3[nH]2)C[C@@H]2CCC[C@@H]21)C1CCOCC1
InChIInChI=1S/C61H76F4N10O8/c1-80-60(78)70-53(32-14-20-82-21-15-32)58(76)74-47-10-6-8-34(47)24-51(74)56-66-43-28-37(39(62)30-45(43)68-56)49-12-13-50(73(49)36-26-41(64)55(42(65)27-36)72-18-4-3-5-19-72)38-29-44-46(31-40(38)63)69-57(67-44)52-25-35-9-7-11-48(35)75(52)59(77)54(71-61(79)81-2)33-16-22-83-23-17-33/h26,28-35,42,47-54H,3-25,27H2,1-2H3,(H,66,68)(H,67,69)(H,70,78)(H,71,79)/t34-,35-,42?,47-,48-,49+,50+,51-,52-,53-,54-/m0/s1
InChIKeyOYFKRPUCAZUFON-RIRHKGLVSA-N
MW1153.33 g/mol
LogP10.07
Rot. Bonds12

About methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate

methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate (PubChem CID 88588746) has the molecular formula C61H76F4N10O8 and a molecular weight of 1153.33 g/mol. Its IUPAC name is methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate.

Molecular Properties

Compound Namemethyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate
PubChem CID88588746
Molecular FormulaC61H76F4N10O8
Molecular Weight1153.33 g/mol
Exact Mass1152.58
IUPAC Namemethyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1[C@H](c2nc3cc(F)c([C@H]4CC[C@H](c5cc6[nH]c([C@@H]7C[C@@H]8CCC[C@@H]8N7C(=O)[C@@H](NC(=O)OC)C7CCOCC7)nc6cc5F)N4C4=CC(F)=C(N5CCCCC5)C(F)C4)cc3[nH]2)C[C@@H]2CCC[C@@H]21)C1CCOCC1
InChIInChI=1S/C61H76F4N10O8/c1-80-60(78)70-53(32-14-20-82-21-15-32)58(76)74-47-10-6-8-34(47)24-51(74)56-66-43-28-37(39(62)30-45(43)68-56)49-12-13-50(73(49)36-26-41(64)55(42(65)27-36)72-18-4-3-5-19-72)38-29-44-46(31-40(38)63)69-57(67-44)52-25-35-9-7-11-48(35)75(52)59(77)54(71-61(79)81-2)33-16-22-83-23-17-33/h26,28-35,42,47-54H,3-25,27H2,1-2H3,(H,66,68)(H,67,69)(H,70,78)(H,71,79)/t34-,35-,42?,47-,48-,49+,50+,51-,52-,53-,54-/m0/s1
InChIKeyOYFKRPUCAZUFON-RIRHKGLVSA-N
XLogP10.07
TPSA199.58 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds12
Heavy Atoms83
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001153.33
LogP ≤ 510.07
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate?
The IUPAC name of methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate (CID 88588746) is methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate.
What is the SMILES notation for methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate?
The canonical SMILES for methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate is COC(=O)N[C@H](C(=O)N1[C@H](c2nc3cc(F)c([C@H]4CC[C@H](c5cc6[nH]c([C@@H]7C[C@@H]8CCC[C@@H]8N7C(=O)[C@@H](NC(=O)OC)C7CCOCC7)nc6cc5F)N4C4=CC(F)=C(N5CCCCC5)C(F)C4)cc3[nH]2)C[C@@H]2CCC[C@@H]21)C1CCOCC1.
What is the InChIKey of methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate?
The InChIKey is OYFKRPUCAZUFON-RIRHKGLVSA-N. The full InChI is InChI=1S/C61H76F4N10O8/c1-80-60(78)70-53(32-14-20-82-21-15-32)58(76)74-47-10-6-8-34(47)24-51(74)56-66-43-28-37(39(62)30-45(43)68-56)49-12-13-50(73(49)36-26-41(64)55(42(65)27-36)72-18-4-3-5-19-72)38-29-44-46(31-40(38)63)69-57(67-44)52-25-35-9-7-11-48(35)75(52)59(77)54(71-61(79)81-2)33-16-22-83-23-17-33/h26,28-35,42,47-54H,3-25,27H2,1-2H3,(H,66,68)(H,67,69)(H,70,78)(H,71,79)/t34-,35-,42?,47-,48-,49+,50+,51-,52-,53-,54-/m0/s1.
What are the key properties of methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate?
methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate has a molecular weight of 1153.33 g/mol, XLogP of 10.07, 12 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[(1S)-2-[(2S,3aS,6aS)-2-[6-[(2R,5R)-5-[2-[(2S,3aS,6aS)-1-[(2S)-2-(methoxycarbonylamino)-2-(oxan-4-yl)acetyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-2-yl]-6-fluoro-3H-benzimidazol-5-yl]-1-(3,5-difluoro-4-piperidin-1-ylcyclohexa-1,3-dien-1-yl)pyrrolidin-2-yl]-5-fluoro-1H-benzimidazol-2-yl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrol-1-yl]-1-(oxan-4-yl)-2-oxoethyl]carbamate is sourced from PubChem (CID 88588746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).